Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Wright Investors Service Comprehensive Report for Alexza Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Jun 2016 Wright Reports 61 $75.00

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review Summary Alexza Pharmaceuticals, Inc. (Alex...

06 Jun 2016 GlobalData 76 $300.00

ValuEngine Rating and Forecast Report for ALXA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

05 Jun 2016 ValuEngine, Inc. 11 $25.00

Termination of coverage - Alexza Pharmaceuticals

Edison Investment Research is terminating coverage on Alexza Pharmaceuticals (ALXA). Please note you should no longer rely on...

02 Jun 2016 Edison Investment Research 1 $10.00

ALEXZA PHARMACEUTICALS - FERRER TO BUY ALEXZA FOR $0.90 PER SHARE PLUS CVR

Ferrer entered into a definitive agreement with Alexza, whereby Ferrer will acquire the company for $0.90 per share in cash, ...

11 May 2016 Edison Investment Research 2 $10.00

Thomson Reuters Stock Report - Alexza Pharmaceuticals Inc (ALXA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review Summary Alexza Pharmaceuticals, Inc. (Alex...

09 Mar 2016 GlobalData 77 $300.00

ALEXZA PHARMACEUTICALS - FERRER SIGNALS INTENT TO POTENTIALLY BUY COMPANY

Alexza disclosed on 26 February that it had entered into a non-binding letter of intent (LOI) from Ferrer on 15 February to a...

08 Mar 2016 Edison Investment Research 6 $10.00

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review Summary Alexza Pharmaceuticals, Inc. (Alex...

03 Dec 2015 GlobalData 84 $300.00

ALEXZA PHARMACEUTICALS - REGAINING ADASUVE RIGHTS AMID STRATEGIC REVIEW

Alexza and Teva have reached an agreement whereby Alexza will reacquire the US commercial rights for Adasuve, with a projecte...

01 Dec 2015 Edison Investment Research 9 $10.00